The FTC and its Seven-Year Subpoena Fight Against Boehringer Ingelheim
It has been nearly seven years since the FTC began its fight with Boehringer Ingelheim Pharmaceuticals Inc. to get documents related to Aggrenox.
It has been nearly seven years since the FTC began its fight with Boehringer Ingelheim Pharmaceuticals Inc. to get documents related to Aggrenox.
In a long drawn out legal battle, the FTC has recently announced that it has reached a settlement to resolve the FTC’s antitrust lawsuit against Cephalon.